ArticleJournal of asthma and allergy2019

Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma.

J Mark FitzGerald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.